
Issued: April 2012.
Eribulin for the treatment of locally advanced or metastatic breast cancer by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2012. Publication and catalogue information, links to buy online and reader comments.